GLI1 and pancreatic neoplasm: Specifically, SMAD2 and 4 were shown to physically interact with GLI1 along with PCAF in pancreatic cancer cells, and enhance GLI1-dependent BCL2 transcription through PCAF-mediated epigenetic activation [94].